Extracorporeal membrane oxygenation (ECMO) is a technology capable of providing short-
term mechanical support to the heart, lungs or both. Over the last decade, the number of …

With an improved median survival of 6.2 years, lung transplantation has become an
increasingly acceptable treatment option for end-stage lung disease. Besides survival …

The development of extracorporeal life support technology has added a new dimension to
the care of critically ill patients who fail conventional treatment options. Extracorporeal …

See page 49 for disclosure information. List of abbreviations: ACT, activated clotting time;
aPTT, activated partial thromboplastin time; ACHD, adult congenital heart disease; ADHF …

Background Extracorporeal membrane oxygenation (ECMO) as a bridge to lung
transplantation (BTT) has become a critical component of caring for patients with end-stage …

Objectives Extracorporeal life support (ECLS) is increasingly used to bridge deteriorating
patients awaiting lung transplantation (LTx), however, few systematic descriptions of this …

Objectives Extracorporeal life support is increasingly used to bridge deteriorating candidates
to lung transplantation. Nevertheless, only few systematic reports with a limited number of …

OBJECTIVES: Extracorporeal membrane oxygenation (ECMO) is an advanced treatment for
acute severe respiratory failure. Patients on ECMO are frequently maintained sedated and …

Objective The use of mechanical circulatory support (MCS) in lung transplantation has been
steadily increasing over the prior decade, with evolving strategies for incorporating support …

Background Extracorporeal membrane oxygenation (ECMO), when used as bridge to lung
transplantation,(BTT) identifies high-risk candidates. Recent advances in cannula design …